SCHEMBL7362362

SCHEMBL7362362

CC1=CN=C(c2cccnc2)[N]1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 13/20 0.50
CYP3A4 P08684 5/20 0.50
ALDH1A1 P00352 3/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2E1 P05181 3/20 0.46
CYP2C9 P11712 3/20 0.46
CYP2B6 P20813 3/20 0.46
CYP2D6 P10635 2/20 0.46
CYP2C19 P33261 2/20 0.46
KDM4E B2RXH2 1/20 0.44
LMNA P02545 1/20 0.44
TP53 P04637 1/20 0.44
MAPT P10636 1/20 0.44
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
HTT P42858 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
HSD17B10 Q99714 1/20 0.44
ALK Q9UM73 1/20 0.41
KIF11 P52732 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7352528 0.76 ATM (0.33) CYP2A6
SCHEMBL7675201 0.72 CYP2A6 (0.52) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2E1
SCHEMBL30473120 0.70 CYP2A6 (1.00) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2E1
SCHEMBL120088 0.70 CYP2A6 (1.00) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2E1
SCHEMBL29419014 0.70 CYP2A6 (1.00) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2E1
Hydrochloric Acid SCHEMBL4831090 0.67 CYP2A6 (0.94) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2E1
SCHEMBL28247322 0.67 CYP2A6 (0.94) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2E1
SCHEMBL27812368 0.67 CYP2A6 (0.94) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2E1
Phosphine SCHEMBL28126457 0.67 CYP2A6 (0.94) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2E1
SCHEMBL28301145 0.67 CYP2A6 (0.94) CYP2A6CYP3A4ALDH1A1CYP1A2CYP2E1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999032454-A9 NITROGEN CONTAINING HETEROAROMATICS WITH ORTHO-SUBSTITUTED P1'S AS FACTOR XA INHIBITORS DU PONT PHARM CO (US) 2001-05-31 WO disclosed
EP-1042299-A1 NITROGEN CONTAINING HETEROAROMATICS WITH ORTHO-SUBSTITUTED P1'S AS FACTOR XA INHIBITORS Du Pont Pharmaceuticals Company (US) 2000-10-11 EP disclosed
EP-0946508-A1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS Du Pont Pharmaceuticals Company (US) 1999-10-06 EP disclosed
EP-0946528-A2 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS Du Pont Pharmaceuticals Company (US) 1999-10-06 EP disclosed
WO-1999032454-A1 NITROGEN CONTAINING HETEROAROMATICS WITH ORTHO-SUBSTITUTED P1'S AS FACTOR XA INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 1999-07-01 WO disclosed
WO-1998028282-A2 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 1998-07-02 WO disclosed
WO-1998028269-A1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 1998-07-02 WO disclosed